Japan to Conduct 1st Clinical Study of Ebola Vaccine
Newsfrom JapanSociety Lifestyle
Tokyo, Dec. 5 (Jiji Press)--A Japanese team said Thursday it will start soon a clinical study of an Ebola vaccine, the country's first clinical research into a vaccine against the deadly virus.
The team, led by professors Hiroshi Yotsuyanagi and Yoshihiro Kawaoka of the University of Tokyo's Institute of Medical Science, will examine the safety and effectiveness of the vaccine developed by the team.
The team will remove genes necessary for the Ebola virus to proliferate and kill the virus with chemicals. Proteins that will remain after the treatment will be used to make the vaccine.
Healthy adult men will be vaccinated. The team will observe them to see whether they acquire immunity against the disease.
Development of such immunity was confirmed in a test on crab-eating monkeys.
[Copyright The Jiji Press, Ltd.]